Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

In view of the fact that peripheral blood parameters have been reported as predictors of immunotherapy to various cancers, this study aimed to determine the predictors of response to anti-programmed death-1 (a...

Source: Cancer Cell International - July 7, 2021 Category: Cancer & Oncology Authors: Xianbin Wu, Runkun Han, Yanping Zhong, Nuoqing Weng and Ao Zhang Tags: Primary research Source Type: research